Welcome to our dedicated page for Centene Del news (Ticker: CNC), a resource for investors and traders seeking the latest updates and insights on Centene Del stock.
Centene Corporation (NYSE: CNC) generates a steady flow of news related to government-sponsored healthcare programs, local health plans, and community health initiatives. As a Fortune 500 healthcare enterprise, Centene and its subsidiaries regularly issue updates on Medicaid and Medicare activities, Marketplace products, investor communications, and efforts to address social drivers of health such as food insecurity.
News items for Centene often feature announcements from local health plans that are companies of Centene Corporation. Examples include Health Net in California, Meridian Health Plan of Illinois, Ambetter Health Marketplace offerings, Coordinated Care in Washington, and specialty pharmacy activities from AcariaHealth. These stories cover topics such as value-based care partnerships, emergency assistance for members during natural disasters, public service announcements promoting preventive care, and investments in food banks and mobile pantry programs.
Investors and analysts following CNC can also find coverage of earnings-related events and financial communications. Centene files Form 8-K reports on quarterly results, updates to financial guidance, participation in healthcare conferences, and changes in board composition. These disclosures provide insight into the company’s financial outlook, use of non-GAAP measures, and governance developments.
For stakeholders interested in public health and community impact, Centene-related news highlights grants and collaborations with food banks, community organizations, and nutrition programs across multiple states. These initiatives illustrate how the enterprise and the Centene Foundation seek to improve access to nutritious food and support whole-person health. This news page brings together such corporate, financial, and community-focused updates for Centene Corporation and its affiliated health plans.
The Behavioral Health Center of Excellence (BHCOE) has teamed up with Centene Corporation (NYSE:CNC) to enhance Applied Behavioral Analysis (ABA) treatment delivery, targeting improved access for individuals with autism and related developmental disabilities. This partnership leverages BHCOE's expertise in quality measurement with Centene's commitment to integrated healthcare services. With a reported 18% rise in autism diagnoses among children from 2016 to 2018, this collaboration aims to establish national healthcare quality standards for behavioral health and improve ABA services within a value-based care framework.
Centene Corporation (NYSE: CNC) announced that its Missouri subsidiary, Home State Health, has secured the MO HealthNet Managed Care General Plan and Specialty Plan. This contract allows Home State to serve various Medicaid programs, including 40,000 foster children. The plan aims to provide trauma-informed healthcare services for children in custody. This one-year contract also includes options for four renewals. Currently, Home State Health supports over 300,000 Medicaid enrollees and partners with 25,000 healthcare providers in Missouri.
Investor consortium led by Nautic Partners, The Vistria Group, and General Atlantic has reached a definitive agreement to acquire PANTHERx Rare from Centene Corporation (NYSE: CNC). This strategic move aims to accelerate PANTHERx's growth as a specialty pharmacy for rare and orphan diseases. With a focus on meeting the unique needs of patients, the consortium anticipates leveraging expertise to drive innovation. The transaction awaits clearance under the Hart-Scott Rodino Act and other customary conditions. PANTHERx is recognized for its achievements in the specialty pharmacy sector.
Centene Corporation (NYSE: CNC) announced the sale of two pharmacy businesses, Magellan Rx and PANTHERx, to Prime Therapeutics and a consortium respectively, generating approximately $2.8 billion in proceeds. This move aligns with Centene's strategy to exit the Pharmacy Benefit Management space, enhancing value creation. Magellan Rx, acquired in January 2022, is known for specialty drug management, while PANTHERx, acquired in December 2020, excels in rare pharmacy. The transactions are expected to be neutral to slightly accretive to Centene’s Adjusted Earnings Per Share post-closing.
Centene Corporation (NYSE: CNC) will present at the Bank of America 2022 Healthcare Conference in Las Vegas from May 9-13, 2022. The company's presentation is scheduled for May 10 at 8:40 a.m. PT, with a live audio webcast available at this link. A replay will be accessible on Centene's website under the Investors section afterwards. Centene is a leading healthcare enterprise focused on providing integrated, cost-effective services, particularly for under-insured and uninsured individuals.
Centene Corporation (NYSE: CNC) reported Q1 2022 results showing a diluted EPS of $1.44 and an adjusted diluted EPS of $1.83, with total revenues of $37.2 billion, up 24% year-over-year. Membership rose by 1.9 million to 26.2 million. The health benefits ratio stood at 87.3%, a slight increase from last year. Additionally, the company raised its 2022 revenue and EPS guidance, projecting adjusted EPS between $5.40 to $5.55.
CEO Sarah London emphasized ongoing operational excellence as key to sustainable growth.
On April 21, 2022, Meridian of Michigan highlighted the rising issue of cyberbullying among the youth, emphasizing its negative impacts on mental health. A Pew Research study indicates that 59% of U.S. teens have experienced online harassment. Meridian's Chief Medical Officer, Dr. Kay Judge, notes the challenges this presents for parents and the community. To combat this, Meridian encourages youth participation in the Centene Institute Youth Impact Award for Cyberbullying Prevention, with a submission deadline of May 20, 2022. The initiative aims to promote awareness and prevention strategies.
Centene Corporation's Board of Directors has accepted the resignation of Leslie V. Norwalk as a Board member. The Board expresses appreciation for her service. The company has been enhancing its corporate governance since November 2021 by appointing five new Board members, refreshing committee chairs, separating the CEO and Chairman roles, and appointing a new lead independent director. The Board supports CEO Sarah London and her leadership team in executing the company's value creation strategy.
Meridian Michigan has appointed Dr. Kay Judge as its new Chief Medical Officer, effective April 10, 2022. Dr. Judge brings over 20 years of experience from health systems in Michigan and California, including her role as Regional Medical Director at Health Net, a Centene subsidiary. She is recognized for her work in reducing healthcare disparities and implementing technology to enhance health outcomes. Dr. Judge aims to uphold Meridian's reputation for high-quality managed care. Meridian is a subsidiary of Centene Corp. (NYSE: CNC), serving Medicaid and Medicare-Medicaid populations in Michigan.
Centene Corporation (NYSE: CNC) will host its 2022 Annual Meeting of Stockholders on April 26, 2022, at 11:00 a.m. ET, following the release of its first-quarter financial results. The meeting will be held at Centene's headquarters in St. Louis, Missouri. Attendees can access a live audio webcast via the company's investor relations website. Centene emphasizes its commitment to providing integrated healthcare services, focusing on underserved populations, including Medicaid and Medicare members.